Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Myriam Curet, Executive Vice President and Chief Medical (TASE:BLWV) Officer at Intuitive Surgical Inc (NASDAQ:ISRG), a $177.75 billion medical technology company trading at a premium P/E ratio of 68, sold 4,500 shares of common stock on July 25, 2025, at a price of $492.48, for a total value of $2.2 million.
On the same day, Curet also exercised options to acquire 4,500 shares of Intuitive Surgical common stock at a price of $242.3367, for a total value of $1.09 million.
Following the sale, Curet directly owns 353 shares of Intuitive Surgical. The option exercise relates to non-qualified stock options that expire on August 28, 2030.
The transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
In other recent news, Intuitive Surgical reported impressive second-quarter results, with revenue reaching $2.44 billion, marking a 21% increase and surpassing consensus estimates by 4%. The company’s earnings per share also exceeded expectations, reaching $2.19, a 23% increase compared to the previous year. RBC Capital responded by raising its price target for Intuitive Surgical from $605 to $615, maintaining an Outperform rating. Similarly, Bernstein SocGen Group increased its price target to $685, citing the broad launch of the da Vinci (EPA:SGEF) 5 surgical system. In contrast, Erste Group downgraded the stock from Buy to Hold, expressing concerns over valuation and margin pressure. Stifel reiterated a Buy rating with a $670 price target, noting the successful placement of 180 DV5 systems in the second quarter. Raymond (NSE:RYMD) James also maintained its Outperform rating, highlighting the strong financial performance across all business segments. These developments reflect the continued interest and varied perspectives from analysts on Intuitive Surgical’s financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.